Intercure Ltd. Logo

Intercure Ltd.

Produces and distributes GMP-certified, pharmaceutical-grade medical cannabis products.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA

Description

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-14 00:57
InterCure Provides an Update Regarding Nir Oz Facility
English 36.2 KB
2024-02-14 00:51
6K-Rami Levy, resigned as the Chief of Operations of Intercure
English 116.7 KB
2024-02-14 00:51
6K-Rami Levy, resigned as the Chief of Operations of Intercure
English 36.2 KB
2024-01-31 17:18
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
English 140.8 KB
2024-01-31 17:18
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
English 36.2 KB
2023-12-15 00:26
6K-Annual General Meeting Results
English 120.2 KB
2023-12-15 00:26
6K-Annual General Meeting Results
English 36.3 KB
2023-11-09 00:28
ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023
English 115.7 KB
2023-11-09 00:28
ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023
English 207.1 KB
2023-11-09 00:28
ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023
English 110.5 KB
2023-10-31 23:34
FORM 6-K-InterCure Wins Cannolam Arbitration Proceeding
English 141.0 KB
2023-10-31 23:34
FORM 6-K-InterCure Wins Cannolam Arbitration Proceeding
English 36.2 KB
2023-10-18 01:40
InterCure Provides an Update Regarding the Security Situation in Israel
English 131.0 KB
2023-10-18 01:40
InterCure Provides an Update Regarding the Security Situation in Israel
English 36.2 KB
2023-09-01 03:36
FINANCIAL STATEMENTS As of June 30, 2023
English 205.8 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Intercure Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.